198 related articles for article (PubMed ID: 21816446)
1. Treatment of genetically obese mice with the iminosugar N-(5-adamantane-1-yl-methoxy-pentyl)-deoxynojirimycin reduces body weight by decreasing food intake and increasing fat oxidation.
Langeveld M; van den Berg SA; Bijl N; Bijland S; van Roomen CP; Houben-Weerts JH; Ottenhoff R; Houten SM; van Dijk KW; Romijn JA; Groen AK; Aerts JM; Voshol PJ
Metabolism; 2012 Jan; 61(1):99-107. PubMed ID: 21816446
[TBL] [Abstract][Full Text] [Related]
2. Modulation of glycosphingolipid metabolism significantly improves hepatic insulin sensitivity and reverses hepatic steatosis in mice.
Bijl N; Sokolović M; Vrins C; Langeveld M; Moerland PD; Ottenhoff R; van Roomen CP; Claessen N; Boot RG; Aten J; Groen AK; Aerts JM; van Eijk M
Hepatology; 2009 Nov; 50(5):1431-41. PubMed ID: 19731235
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of glycosphingolipid synthesis induces a profound reduction of plasma cholesterol and inhibits atherosclerosis development in APOE*3 Leiden and low-density lipoprotein receptor-/- mice.
Bietrix F; Lombardo E; van Roomen CP; Ottenhoff R; Vos M; Rensen PC; Verhoeven AJ; Aerts JM; Groen AK
Arterioscler Thromb Vasc Biol; 2010 May; 30(5):931-7. PubMed ID: 20167657
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of glycolipid biosynthesis by N-(5-adamantane-1-yl-methoxy-pentyl)-deoxynojirimycin protects against the inflammatory response in hapten-induced colitis.
Shen C; Bullens D; Kasran A; Maerten P; Boon L; Aerts JM; Van Assche G; Geboes K; Rutgeerts P; Ceuppens JL
Int Immunopharmacol; 2004 Jul; 4(7):939-51. PubMed ID: 15182733
[TBL] [Abstract][Full Text] [Related]
5. The glucosylceramide synthase inhibitor N-(5-adamantane-1-yl-methoxy-pentyl)-deoxynojirimycin induces sterol regulatory element-binding protein-regulated gene expression and cholesterol synthesis in HepG2 cells.
Bijl N; Scheij S; Houten S; Boot RG; Groen AK; Aerts JM
J Pharmacol Exp Ther; 2008 Sep; 326(3):849-55. PubMed ID: 18550691
[TBL] [Abstract][Full Text] [Related]
6. Chronic C75 treatment of diet-induced obese mice increases fat oxidation and reduces food intake to reduce adipose mass.
Thupari JN; Kim EK; Moran TH; Ronnett GV; Kuhajda FP
Am J Physiol Endocrinol Metab; 2004 Jul; 287(1):E97-E104. PubMed ID: 14736702
[TBL] [Abstract][Full Text] [Related]
7. Reduction of glycosphingolipid biosynthesis stimulates biliary lipid secretion in mice.
Bijl N; van Roomen CP; Triantis V; Sokolovic M; Ottenhoff R; Scheij S; van Eijk M; Boot RG; Aerts JM; Groen AK
Hepatology; 2009 Feb; 49(2):637-45. PubMed ID: 19072830
[TBL] [Abstract][Full Text] [Related]
8. GLP-1-derived nonapeptide GLP-1(28-36)amide inhibits weight gain and attenuates diabetes and hepatic steatosis in diet-induced obese mice.
Tomas E; Wood JA; Stanojevic V; Habener JF
Regul Pept; 2011 Aug; 169(1-3):43-8. PubMed ID: 21549160
[TBL] [Abstract][Full Text] [Related]
9. N-butyldeoxynojirimycin causes weight loss as a result of appetite suppression in lean and obese mice.
Priestman DA; van der Spoel AC; Butters TD; Dwek RA; Platt FM
Diabetes Obes Metab; 2008 Feb; 10(2):159-66. PubMed ID: 18190430
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of liver fatty acid oxidation in the leptin-deficient obese mouse.
Brix AE; Elgavish A; Nagy TR; Gower BA; Rhead WJ; Wood PA
Mol Genet Metab; 2002 Mar; 75(3):219-26. PubMed ID: 11914033
[TBL] [Abstract][Full Text] [Related]
11. Correction of liver steatosis by a hydrophobic iminosugar modulating glycosphingolipids metabolism.
Lombardo E; van Roomen CP; van Puijvelde GH; Ottenhoff R; van Eijk M; Aten J; Kuiper J; Overkleeft HS; Groen AK; Verhoeven AJ; Aerts JM; Bietrix F
PLoS One; 2012; 7(10):e38520. PubMed ID: 23056165
[TBL] [Abstract][Full Text] [Related]
12. A novel aminosterol reverses diabetes and fatty liver disease in obese mice.
Takahashi N; Qi Y; Patel HR; Ahima RS
J Hepatol; 2004 Sep; 41(3):391-8. PubMed ID: 15336441
[TBL] [Abstract][Full Text] [Related]
13. Amylin improves the effect of leptin on insulin sensitivity in leptin-resistant diet-induced obese mice.
Kusakabe T; Ebihara K; Sakai T; Miyamoto L; Aotani D; Yamamoto Y; Yamamoto-Kataoka S; Aizawa-Abe M; Fujikura J; Hosoda K; Nakao K
Am J Physiol Endocrinol Metab; 2012 Apr; 302(8):E924-31. PubMed ID: 22275759
[TBL] [Abstract][Full Text] [Related]
14. Molecular therapy for obesity and diabetes based on a long-term increase in hepatic fatty-acid oxidation.
Orellana-Gavaldà JM; Herrero L; Malandrino MI; Pañeda A; Sol Rodríguez-Peña M; Petry H; Asins G; Van Deventer S; Hegardt FG; Serra D
Hepatology; 2011 Mar; 53(3):821-32. PubMed ID: 21319201
[TBL] [Abstract][Full Text] [Related]
15. Chronic ethanol consumption lessens the gain of body weight, liver triglycerides, and diabetes in obese ob/ob mice.
Fromenty B; Vadrot N; Massart J; Turlin B; Barri-Ova N; Lettéron P; Fautrel A; Robin MA
J Pharmacol Exp Ther; 2009 Oct; 331(1):23-34. PubMed ID: 19587315
[TBL] [Abstract][Full Text] [Related]
16. Anti-obesity effects of KR-66195, a synthetic DPP-IV inhibitor, in diet-induced obese mice and obese-diabetic ob/ob mice.
Lee EY; Kim YW; Oh H; Choi CS; Ahn JH; Lee BW; Kang ES; Cha BS; Lee HC
Metabolism; 2014 Jun; 63(6):793-9. PubMed ID: 24684824
[TBL] [Abstract][Full Text] [Related]
17. The Iminosugar AMP-DNM Improves Satiety and Activates Brown Adipose Tissue Through GLP1.
Herrera Moro Chao D; Wang Y; Foppen E; Ottenhoff R; van Roomen C; Parlevliet ET; van Eijk M; Verhoek M; Boot R; Marques AR; Scheij S; Mirzaian M; Kooijman S; Jansen K; Wang D; Mergen C; Seeley RJ; Tschöp MH; Overkleeft H; Rensen PCN; Kalsbeek A; Aerts JMFG; Yi CX
Diabetes; 2019 Dec; 68(12):2223-2234. PubMed ID: 31578192
[TBL] [Abstract][Full Text] [Related]
18. Reducing glycosphingolipid content in adipose tissue of obese mice restores insulin sensitivity, adipogenesis and reduces inflammation.
van Eijk M; Aten J; Bijl N; Ottenhoff R; van Roomen CP; Dubbelhuis PF; Seeman I; Ghauharali-van der Vlugt K; Overkleeft HS; Arbeeny C; Groen AK; Aerts JM
PLoS One; 2009; 4(3):e4723. PubMed ID: 19305508
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological inhibition of glucosylceramide synthase enhances insulin sensitivity.
Aerts JM; Ottenhoff R; Powlson AS; Grefhorst A; van Eijk M; Dubbelhuis PF; Aten J; Kuipers F; Serlie MJ; Wennekes T; Sethi JK; O'Rahilly S; Overkleeft HS
Diabetes; 2007 May; 56(5):1341-9. PubMed ID: 17287460
[TBL] [Abstract][Full Text] [Related]
20. Green tea (-)-epigallocatechin-3-gallate reduces body weight with regulation of multiple genes expression in adipose tissue of diet-induced obese mice.
Lee MS; Kim CT; Kim Y
Ann Nutr Metab; 2009; 54(2):151-7. PubMed ID: 19390166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
